NelsonLabs.com is best viewed in Chrome, Firefox, Safari, and Internet Explorer 9 and above.
Version: 1.1.5037.23448-7fe1cda529b97ebc52da0f2bbefb0d41deb9638a

The website will be unavailable on 10 Sept 2016 between 6–7PM MST.

Irritation Testing

Irritation Testing

The Biocompatibility Irritation test determines if a material or device with which a patient would have contact is an irritant. It measures the reaction to a single, repeated or continual exposure from device materials that may produce skin, mucosal or ocular irritation. Irritation is a local tissue response characterized by the usual signs of inflammation, redness and swelling, and could be accompanied by heat and pain. This test complies with ISO 10993-10 and ISO 10993-12 standards.

Download the biocompatibility test matrix. [Based on ISO 10993-1:2010 (E) and FDA G95-1 Guidelines]

Applicable Standards

  • ISO 10993

Test Options

Standard turn around times (TAT) are listed below. Ask an expert for a specific consultation on your product. If you are ready to submit your samples for testing, click here to fill out the Sample Submission Form.

Code Test TAT (days) Request Quote
SCX210 Irritation: Intracutaneous Reactivity (USP), 2 extracts Add
SCX220 Irritation: Intracutaneous Toxicity (ISO), 2 extracts Add
SCX230 Irritation: Primary Eye, 2 extracts Add
SCX240 Irritation: Primary Skin, each Add
SCX250 Irritation: Bladder, each Add
SCX260 Irritation: Vaginal, Direct exposure method for liquids Add
SCX265 Irritation: Vaginal, Device method, 2 extracts Add
SCX270 Irritation: Oral Mucosal w/ histo, 2 extracts Add
SCX275 Irritation: Oral Mucosal w/ histo, Direct exposure Add
SCX210 - Irritation: Intracutaneous Reactivity (USP), 2 extracts
Standard TAT not available for this product
SCX220 - Irritation: Intracutaneous Toxicity (ISO), 2 extracts
Standard TAT not available for this product
SCX230 - Irritation: Primary Eye, 2 extracts
Standard TAT not available for this product
SCX240 - Irritation: Primary Skin, each
Standard TAT not available for this product
SCX250 - Irritation: Bladder, each
Standard TAT not available for this product
SCX260 - Irritation: Vaginal, Direct exposure method for liquids
Standard TAT not available for this product
SCX265 - Irritation: Vaginal, Device method, 2 extracts
Standard TAT not available for this product
SCX270 - Irritation: Oral Mucosal w/ histo, 2 extracts
Standard TAT not available for this product
SCX275 - Irritation: Oral Mucosal w/ histo, Direct exposure
Standard TAT not available for this product

Sample Specifications

SCX210: Turn Around Time is 35 days from PDS approval. 2 complete devices, each device must be 120 cm2 or 4 grams.
SCX220: Turn Around Time is 35 days from PDS approval. 2 complete devices, each device must be 120 cm2 or 4 grams.
SCX230: Turn Around Time is 35 days from PDS approval. 2 complete device, each device must be 120 cm2 or 4 grams.
SCX240: Turn Around Time is 35 days from PDS approval. 8 samples, each 1 inch^2 pieces
SCX250: Turn Around Time will be determined after PDS approval
SCX260: Turn Around Time is 56 days from PDS approval. Minimum 25 mL.
SCX265: Turn Around Time is 56 days from PDS approval. 10 complete devices, each device must be 120 cm2 or 4 grams.
SCX270: Turn Around Time is 70 days from PDS approval. 3 complete devices, each device must be 120 cm2 or 4 grams.
SCX275: Turn Around Time is 70 days from PDS approval. 10 discs, sized 1.5cm diameter x 0.5cm thick.

Study Outline

The intracutaneous irritation test evaluates the safety of a biomaterial sample by injecting rabbits intracutaneously with extracts of the test article and associated vehicle controls. Injection sites will be examined and scored at 24 ± 2, 48 ± 2 and 72 ± 2 hours after treatment for signs of skin reactions.
Chat Now